MHLW: Condition Has Improved In 70% Of Cervical Cancer Vaccine Patients Receiving Treatment
This article was originally published in PharmAsia News
Executive Summary
A MHLW Japan research team now reports that the condition of about 70% of patients who continued treatment after inoculation with cervical cancer vaccine has improved, following incidents in which many Japanese women were hit with side effects such as severe pain.